+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Factor VIII"

Global Hemophilia Market: Size, Trends & Forecast with Impact of COVID-19 (2022-2026) - Product Thumbnail Image

Global Hemophilia Market: Size, Trends & Forecast with Impact of COVID-19 (2022-2026)

  • Report
  • February 2022
  • 97 Pages
  • Global
From
Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product; Disease; Treatment Type; Therapy; End User, and Geography - Product Thumbnail Image

Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product; Disease; Treatment Type; Therapy; End User, and Geography

  • Report
  • February 2020
  • 225 Pages
  • Global
From
Hemophilia A - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hemophilia A - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 140 Pages
  • Global
From
Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 283 Pages
  • Global
From
Hemlibra (Emicizumab-kxwh) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Hemlibra (Emicizumab-kxwh) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • Global
From
Investigation Report on the Chinese Recombinant Human Erythropoietin(rhEPO) Market, 2020-2024 - Product Thumbnail Image

Investigation Report on the Chinese Recombinant Human Erythropoietin(rhEPO) Market, 2020-2024

  • Report
  • September 2020
  • 50 Pages
  • China
From
Investigation Report on China Recombinant Factor VIII (rFVIII) Market 2020-2024 - Product Thumbnail Image

Investigation Report on China Recombinant Factor VIII (rFVIII) Market 2020-2024

  • Report
  • September 2020
  • 40 Pages
  • China
From
Investigation Report on China's Prothrombin Complex Concentrate (PCC) Market, 2019-2023 - Product Thumbnail Image

Investigation Report on China's Prothrombin Complex Concentrate (PCC) Market, 2019-2023

  • Report
  • September 2019
  • 30 Pages
  • China
From
Investigation Report on Recombinant Human Coagulation Factor VIII in China, 2018-2022 - Product Thumbnail Image

Investigation Report on Recombinant Human Coagulation Factor VIII in China, 2018-2022

  • Report
  • June 2018
  • 30 Pages
  • China
From
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • March 2023
  • 394 Pages
  • Global
From
Hemophilia A and B - Epidemiology Forecast to 2030 - Product Thumbnail Image

Hemophilia A and B - Epidemiology Forecast to 2030

  • Report
  • October 2021
  • 54 Pages
  • Global
From
Hemophilia A (Factor VIII Deficiency) Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Hemophilia A (Factor VIII Deficiency) Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • May 2020
  • 344 Pages
  • Global
From
Hemophilia: Epidemiology Forecast to 2028 - Product Thumbnail Image

Hemophilia: Epidemiology Forecast to 2028

  • Report
  • July 2019
  • 48 Pages
  • Global
From
Hemophilia A - Pipeline Review, H2 2019 - Product Thumbnail Image

Hemophilia A - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 212 Pages
  • Global
From
Human Coagulation Factor VIII Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Human Coagulation Factor VIII Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • November 2023
  • 111 Pages
  • Global
From
Recombinant Coagulation Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Recombinant Coagulation Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • November 2023
  • 108 Pages
  • Global
From
Factor VIII Deficiency Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Factor VIII Deficiency Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 99 Pages
  • Global
From
Plasma-derived Factor VIII Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Plasma-derived Factor VIII Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 101 Pages
  • Global
From
Recombinant Factor VIII Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Recombinant Factor VIII Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 96 Pages
  • Global
From
Loading Indicator

The Factor VIII market is a segment of the hematological drugs market, which includes drugs used to treat blood-related disorders. Factor VIII is a protein that helps blood to clot, and is used to treat hemophilia A, a genetic disorder that impairs the body's ability to form blood clots. Factor VIII is typically administered intravenously, and is available in both recombinant and plasma-derived forms. The Factor VIII market is highly competitive, with a number of companies offering products. These include Novo Nordisk, Pfizer, Bayer, CSL Behring, and Shire. Additionally, there are several smaller companies that offer Factor VIII products, such as Octapharma, Kedrion, and Biotest. Show Less Read more